Effects of denosumab treatment in chronic liver disease patients with osteoporosis

• 作 者: Chisato Saeki Mitsuru Saito Ts
• 机 构: DivisionofGastroenterologyandHepatology,DepartmentofOrthopaedicSurgery,CoreResearchFacilities
• 出 处: 世界胃肠病学杂志:英文版
• 发表日期: 2020年33期
• 关键词: Chronic liver disease DENOSUMAB OSTEOPOROSIS Bone mineral density Bone turnover

BACKGROUND Effective treatment of osteoporosis is essential for improving morbidity and health-related quality of life in chronic liver disease(CLD)patients.Denosumab has been shown to increase bone mineral density(BMD)and decrease the risk of osteoporoti